Hajime Uno

Hajime Uno

UNVERIFIED PROFILE

Are you Hajime Uno?   Register this Author

Register author
Hajime Uno

Hajime Uno

Publications by authors named "Hajime Uno"

Are you Hajime Uno?   Register this Author

100Publications

2250Reads

44Profile Views

Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization.

Cancer 2019 Oct 8. Epub 2019 Oct 8.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32549DOI Listing
October 2019

Clinical factors associated with urinary tract cancer in individuals with Lynch syndrome.

Cancer Epidemiol Biomarkers Prev 2019 Oct 15. Epub 2019 Oct 15.

Population Sciences, Dana-Farber/Brigham and Women's Cancer Center

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-19-0213DOI Listing
October 2019

Patient-preferred outcomes measurement after post-mastectomy radiation therapy and immediate reconstruction.

Breast J 2019 Sep 8. Epub 2019 Sep 8.

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13592DOI Listing
September 2019

How Do the Accrual Pattern and Follow-Up Duration Affect the Hazard Ratio Estimate When the Proportional Hazards Assumption Is Violated?

Oncologist 2019 Jul 10;24(7):867-871. Epub 2018 Sep 10.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656438PMC
July 2019

Unifying Design and Analysis for Superiority and Noninferiority Trials With Appropriate End Point.

JAMA Surg 2019 May;154(5):466-467

Department of Biostatistics, Harvard University, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamasurg.2018.5852DOI Listing
May 2019

Effect of marijuana smoking on pulmonary disease in HIV-infected and uninfected men: a longitudinal cohort study.

EClinicalMedicine 2019 Jan 24;7:55-64. Epub 2019 Jan 24.

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eclinm.2019.01.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402353PMC
January 2019

Determining the Time of Cancer Recurrence Using Claims or Electronic Medical Record Data.

JCO Clin Cancer Inform 2018 12;2:1-10

Hajime Uno, Angel M. Cronin, and Michael J. Hassett, Dana-Farber Cancer Institute, Boston, MA; Debra P. Ritzwoller and Nikki M. Carroll, Kaiser Permanente Colorado, Denver, CO; and Mark C. Hornbrook, Kaiser Permanente Center for Health Research, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.17.00163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338474PMC
December 2018

Low T-cell subsets prior to development of virus-associated cancer in HIV-seronegative men who have sex with men.

Cancer Causes Control 2018 Nov 12;29(11):1131-1142. Epub 2018 Oct 12.

Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Center for Life Science 1010, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-018-1090-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245112PMC
November 2018

Commentary: PREMM5 threshold of 2.5% is recommended to improve identification of PMS2 carriers.

Fam Cancer 2018 10;17(4):567

Population Sciences Division, Dana-Farber Cancer Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-018-0074-6DOI Listing
October 2018

Estrogen-receptor status and risk of contralateral breast cancer following DCIS.

Breast Cancer Res Treat 2018 Oct 26;171(3):777-781. Epub 2018 Jun 26.

Department of Radiation Therapy, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4860-5DOI Listing
October 2018

Interpreting the Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma.

JAMA Oncol 2018 08;4(8):1135-1136

Department of Biostatistics, Harvard University, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.0881DOI Listing
August 2018

Estimating and Interpreting the Overall Survival Benefit of Checkpoint Inhibitors via Meta-analysis.

JAMA Oncol 2018 08;4(8):1137-1138

Department of Biostatistics, Harvard University, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.1087DOI Listing
August 2018

A flexible and coherent test/estimation procedure based on restricted mean survival times for censored time-to-event data in randomized clinical trials.

Stat Med 2018 07 22;37(15):2307-2320. Epub 2018 Apr 22.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.7661DOI Listing
July 2018

Efficiency of two sample tests via the restricted mean survival time for analyzing event time observations.

Biometrics 2018 06 12;74(2):694-702. Epub 2017 Sep 12.

Department of Biostatistics, Harvard University, Boston, Massachusetts 02115, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/biom.12770DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847424PMC
June 2018

Poor performance of clinical prediction models: the harm of commonly applied methods.

J Clin Epidemiol 2018 06 24;98:133-143. Epub 2017 Nov 24.

Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2017.11.013DOI Listing
June 2018

Quantification of Long-term Survival Benefit in a Comparative Oncology Clinical Study.

JAMA Oncol 2018 06;4(6):881-882

Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.0518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145678PMC
June 2018

Assessing Metronomic Chemotherapy for Progressive Pediatric Solid Malignant Tumors.

JAMA Oncol 2018 05;4(5):743

Department of Biostatistics, Harvard University, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.3983DOI Listing
May 2018

Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer.

JAMA Oncol 2018 04;4(4):585

Department of Biostatistics, Harvard University, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.0487DOI Listing
April 2018

Comparing Survival After Recurrent vs De Novo Stage IV Advanced Breast, Lung, and Colorectal Cancer.

JNCI Cancer Spectr 2018 Apr 28;2(2):pky024. Epub 2018 Jun 28.

Kaiser Permanente Colorado, Institute for Health Research, Denver, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncics/pky024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024888PMC
April 2018

Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab as a Result of Adverse Events Lived Significantly Longer Than Patients Who Continued Treatment.

J Clin Oncol 2018 03 16;36(7):720-721. Epub 2018 Jan 16.

Miki Horiguchi, Kitasato University School of Pharmacy, Tokyo, Japan; Hajime Uno, Dana-Farber Cancer Institute, Boston, MA; and Lee-Jen Wei, Department of Biostatistics, Harvard University, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.0983DOI Listing
March 2018

Evaluating Noninferiority With Clinically Interpretable Statistics for the PROSELICA Study to Assess Treatment Efficacy of a Reduced Dose of Cabazitaxel for Treating Metastatic Prostate Cancer.

J Clin Oncol 2018 03 26;36(8):825-826. Epub 2018 Jan 26.

Miki Horiguchi, Kitasato University School of Pharmacy, Tokyo, Japan; Hajime Uno, Dana-Farber Cancer Institute, Boston, MA; and Lee-Jen Wei, Harvard University, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.9829DOI Listing
March 2018

Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer.

JAMA 2018 01;319(3):306

Department of Biostatistics, Harvard University, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2017.18312DOI Listing
January 2018

Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management.

Med Care 2017 12;55(12):e88-e98

*Dana-Farber Cancer Institute †Harvard Medical School, Boston, MA ‡Institute for Health Research, Kaiser Permanente Colorado, Denver, CO §The Center for Health Research, Kaiser Permanente Northwest, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MLR.0000000000000404DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732933PMC
December 2017

Restricted Mean Survival Time as a Measure to Interpret Clinical Trial Results.

JAMA Cardiol 2017 11;2(11):1179-1180

Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2017.2922DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359932PMC
November 2017

Overall Survival in the Randomized Phase II Study Investigating Pazopanib Versus Weekly Paclitaxel in Relapsed or Progressive Urothelial Cancer.

J Clin Oncol 2017 10 11;35(29):3373. Epub 2017 Aug 11.

Miki Horiguchi, Kitasato University School of Pharmacy, Tokyo, Japan; Hajime Uno, Dana-Farber Cancer Institute, Boston, MA; and Lee-Jen Wei, Harvard University, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.73.8120
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.73.8120DOI Listing
October 2017

Decision on performing interim analysis for comparative clinical trials.

Contemp Clin Trials Commun 2017 Sep 16;7:224-230. Epub 2017 Aug 16.

Dana Farber Cancer Institute, Department of Medical Oncology, Division of Population Sciences, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.conctc.2017.08.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898570PMC
September 2017

Marijuana Use Impacts Midlife Cardiovascular Events in HIV-Infected Men.

Clin Infect Dis 2017 Aug;65(4):626-635

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cix391DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850013PMC
August 2017

Survival after recurrence of stage I-III breast, colorectal, or lung cancer.

Cancer Epidemiol 2017 08 12;49:186-194. Epub 2017 Jul 12.

Kaiser Permanente Colorado, Institute for Health Research, Denver, CO, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2017.07.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572775PMC
August 2017

Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study.

Cancer Causes Control 2017 Jul 27;28(7):767-777. Epub 2017 Apr 27.

Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Center for Life Science 1010, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-017-0896-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557016PMC
July 2017

Development and Validation of the PREMM Model for Comprehensive Risk Assessment of Lynch Syndrome.

J Clin Oncol 2017 Jul 10;35(19):2165-2172. Epub 2017 May 10.

Fay Kastrinos and Ashley McFarland, Columbia University Medical Center, New York, NY; Hajime Uno, Chinedu Ukaegbu, Matthew B. Yurgelun, Matthew H. Kulke, Deborah Schrag, Jeffrey A. Meyerhardt, Charles S. Fuchs, Robert J. Mayer, Kimmie Ng, and Sapna Syngal, Dana-Farber Cancer Institute; Carmelita Alvero, Harvard T.H. Chan School of Public Health; Matthew B. Yurgelun, Matthew H. Kulke, Deborah Schrag, Jeffrey A. Meyerhardt, Charles S. Fuchs, Robert J. Mayer, Kimmie Ng, and Sapna Syngal, Harvard Medical School; Sapna Syngal, Brigham and Women's Hospital, Boston, MA; and Ewout W. Steyerberg, University Medical Center Rotterdam, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.6120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493047PMC
July 2017

Long-term nitrite inhalant exposure and cancer risk in MSM.

AIDS 2017 05;31(8):1169-1180

aDepartment of Cancer Immunology and Virology bCenter for Population Science, Dana-Farber Cancer Institute, Boston, Massachusetts cDivision of Infectious Diseases, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00002030-201705150-0001
Publisher Site
http://dx.doi.org/10.1097/QAD.0000000000001451DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414542PMC
May 2017

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.

J Clin Oncol 2017 Apr 30;35(10):1086-1095. Epub 2017 Jan 30.

Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Hajime Uno, Chinedu I. Ukaegbu, Lauren K. Brais, Philip G. McNamara, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Dana-Farber Cancer Institute; Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Hajime Uno, Jason L. Hornick, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Harvard Medical School; Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Jason L. Hornick, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Brigham and Women's Hospital, Boston, MA; and Brian A. Allen, John Kidd, Nanda Singh, Anne-Renee Hartman, and Richard J. Wenstrup, Myriad Genetics, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.0012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455355PMC
April 2017

Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.

JAMA Oncol 2017 Jan;3(1):101-104

Division of Population Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.2164DOI Listing
January 2017

Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy.

Science 2017 01;355(6322)

Howard Hughes Medical Institute, Department of Genetics, Harvard Medical School, Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aaf8399DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592794PMC
January 2017

Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes.

Br J Haematol 2016 Dec 21;175(5):829-840. Epub 2016 Sep 21.

Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14305DOI Listing
December 2016

How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy?

J Clin Oncol 2016 11;34(31):3818

Takahiro Hasegawa, Shionogi & Co, Ltd, Osaka, Japan; Hajime Uno, Dana-Farber Cancer Institute, Boston, MA; Lee-Jen Wei, Harvard University, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.2055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477927PMC
November 2016

Reply to comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.

Cancer 2016 10 8;122(20):3244-3245. Epub 2016 Jul 8.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30187DOI Listing
October 2016

Safety Study of Salmeterol in Asthma in Adults.

N Engl J Med 2016 09;375(11):1097

Harvard University, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1608323DOI Listing
September 2016

Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromes.

Br J Haematol 2016 06 23;173(5):713-21. Epub 2016 Feb 23.

Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13987DOI Listing
June 2016

Neratinib after trastuzumab in patients with HER2-positive breast cancer.

Lancet Oncol 2016 05 27;17(5):e176. Epub 2016 Apr 27.

Harvard University, Boston MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)00165-0DOI Listing
May 2016

On the restricted mean survival time curve in survival analysis.

Biometrics 2016 Mar 24;72(1):215-21. Epub 2015 Aug 24.

Department of Biostatistics, Harvard University, Boston, Massachusetts 02115, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/biom.12384DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114026PMC
March 2016

Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer.

N Engl J Med 2016 02;374(5):492-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1514790DOI Listing
February 2016

A versatile test for equality of two survival functions based on weighted differences of Kaplan-Meier curves.

Stat Med 2015 Dec 20;34(28):3680-95. Epub 2015 Jul 20.

Department of Biostatistics, Harvard University, Boston, 02115, MA, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.6591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626406PMC
December 2015

Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database.

Int J Radiat Oncol Biol Phys 2015 Nov 11;93(3):622-30. Epub 2015 Jul 11.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.07.006DOI Listing
November 2015

Adverse Outcomes After Palliative Radiation Therapy for Uncomplicated Spine Metastases: Role of Spinal Instability and Single-Fraction Radiation Therapy.

Int J Radiat Oncol Biol Phys 2015 Oct 9;93(2):373-81. Epub 2015 Jun 9.

Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.06.006DOI Listing
October 2015

Financial hardship and the intensity of medical care received near death.

Psychooncology 2015 May 23;24(5):572-8. Epub 2014 Jul 23.

Dana-Farber Cancer Institute, Boston, MA, USA; Harvard School of Public Health, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.3624DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305037PMC
May 2015

Derivation and validation of the SEER-Medicare myelodysplastic syndromes risk score (SMMRS).

Leuk Res 2014 Dec 30;38(12):1420-4. Epub 2014 Sep 30.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.09.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314368PMC
December 2014

Acute hospital care is the chief driver of regional spending variation in Medicare patients with advanced cancer.

Health Aff (Millwood) 2014 Oct;33(10):1793-800

Deborah Schrag is a professor of medicine at Harvard Medical School and a research scientist at the Dana-Farber Cancer Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2014.0280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203442PMC
October 2014

Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis.

J Clin Oncol 2014 Aug 30;32(22):2380-5. Epub 2014 Jun 30.

Hajime Uno, Deborah Schrag, and Susanna Jacobus, Dana-Farber Cancer Institute; Brian Claggett, Hicham Skali, and Scott Solomon, Harvard Medical School, Brigham and Women's Hospital; Michael Hughes and Lee-Jen Wei, Harvard School of Public Health, Boston, MA; Lu Tian, Stanford University School of Medicine, Palo Alto, CA; Eisuke Inoue and Masahiro Takeuchi, Kitasato University; Toshio Miyata, Health and Global Policy Institute; Yoshiaki Uyama, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan; Paul Gallo, Novartis Pharmaceuticals, East Hanover, NJ; Lihui Zhao, Northwestern University Feinberg School of Medicine, Chicago, IL; and Milton Packer, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.2208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105489PMC
August 2014

Effects of bracing in adolescents with idiopathic scoliosis.

N Engl J Med 2014 02;370(7):680

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1314229DOI Listing
February 2014

A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data.

Stat Med 2013 Jun 5;32(14):2430-42. Epub 2012 Oct 5.

Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/sim.5647
Publisher Site
http://dx.doi.org/10.1002/sim.5647DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734387PMC
June 2013

Mortality rates in trials of subjects with type 2 diabetes.

J Am Heart Assoc 2012 Feb 20;1(1):8-15. Epub 2012 Feb 20.

Cardiovascular Division, Dana Farber Cancer Institute, Boston, MA (E.B., H.S., S.D.S., M.A.P.) ; General Medicine Division, Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston, MA (E.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.111.000059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487314PMC
February 2012

Graphical procedures for evaluating overall and subject-specific incremental values from new predictors with censored event time data.

Biometrics 2011 Dec 19;67(4):1389-96. Epub 2011 Apr 19.

Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1541-0420.2011.01600.x
Publisher Site
http://dx.doi.org/10.1111/j.1541-0420.2011.01600.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144297PMC
December 2011

Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.

J Renin Angiotensin Aldosterone Syst 2011 Dec 11;12(4):483-90. Epub 2011 Jul 11.

Brigham and Women's Hospital, Boston, MA 02115 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1470320311414453DOI Listing
December 2011

Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention.

Circulation 2011 Jun 23;123(23):2674-80. Epub 2011 May 23.

Division of Cardiology, New York-Presbyterian/Columbia University Medical Center, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.110.990655DOI Listing
June 2011

On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.

Stat Med 2011 May 13;30(10):1105-17. Epub 2011 Jan 13.

Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.4154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079915PMC
May 2011

Outcome prediction in sepsis combined use of genetic polymorphisms - A study in Japanese population.

Cytokine 2011 Apr 1;54(1):79-84. Epub 2011 Feb 1.

Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2010.12.001DOI Listing
April 2011

Erythropoietic response and outcomes in kidney disease and type 2 diabetes.

N Engl J Med 2010 Sep;363(12):1146-55

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1005109DOI Listing
September 2010

Calibrating parametric subject-specific risk estimation.

Biometrika 2010 Jun;97(2):389-404

Department of Biostatistics , Harvard University , Boston, Massachusetts 02115 , U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/biomet/asq012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412577PMC
June 2010

Clinical consequences of road traffic injuries among the elderly in Japan.

BMC Public Health 2010 Jun 28;10:375. Epub 2010 Jun 28.

Department of Emergency Medicine, Himeno Hospital, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2458-10-375DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903521PMC
June 2010

Predicted Interval Plots (PIPS): A Graphical Tool for Data Monitoring of Clinical Trials.

Stat Biopharm Res 2009 Nov;1(4):348-355

Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1198/sbr.2009.0041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059316PMC
November 2009